Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $8.2 million.

  • Lifecore Biomedical, Inc. \De\'s Accounts Payables fell 4967.55% to $8.2 million in Q2 2025 from the same period last year, while for May 2025 it was $8.2 million, marking a year-over-year decrease of 4967.55%. This contributed to the annual value of $8.2 million for FY2025, which is 4967.55% down from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Accounts Payables of $8.2 million as of Q2 2025, which was down 4967.55% from $7.4 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Accounts Payables registered a high of $22.1 million during Q2 2023, and its lowest value of $7.4 million during Q1 2025.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Accounts Payables had a median value of $13.3 million in 2022 and averaged $13.3 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Accounts Payables plummeted by 8603.99% in 2021 and then soared by 7060.69% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Accounts Payables (Quarter) stood at $8.7 million in 2021, then soared by 53.68% to $13.3 million in 2022, then soared by 43.02% to $19.0 million in 2023, then fell by 21.32% to $15.0 million in 2024, then tumbled by 45.08% to $8.2 million in 2025.
  • Its Accounts Payables stands at $8.2 million for Q2 2025, versus $7.4 million for Q1 2025 and $15.0 million for Q4 2024.